Skip to main content
AAN.com
Articles
January 22, 2002

Patterns of brain atrophy in frontotemporal dementia and semantic dementia

January 22, 2002 issue
58 (2) 198-208

Abstract

Objective: To identify and compare the patterns of cerebral atrophy associated with two clinical variants of frontotemporal lobar degeneration (FTLD): frontotemporal dementia (FTD) and semantic dementia (SemD).
Methods: Twenty patients with FTLD were classified as having FTD (N = 8) or SemD (N = 12) based on current clinical criteria. Both groups showed a similar spectrum of behavioral abnormalities, as indicated by the neuropsychiatric inventory. T1-weighted MRI was obtained for each patient and 20 control subjects. The regions of focal gray matter tissue loss associated with both FTD and SemD, as well as those differing between the two groups were examined using voxel-based morphometry.
Results: Regions of significant atrophy seen in both groups were located in the ventromedial frontal cortex, the posterior orbital frontal regions bilaterally, the insula bilaterally, and the left anterior cingulate cortex. The FTD, but not the SemD, group showed atrophy in the right dorsolateral frontal cortex and the left premotor cortex. The SemD, but not the FTD, group showed tissue loss in the anterior temporal cortex and the amygdala/anterior hippocampal region bilaterally.
Conclusions: Although FTD and SemD are associated with different overall patterns of brain atrophy, regions of gray matter tissue loss in the orbital frontal, insular, and anterior cingulate regions are present in both groups. The authors suggest that pathology in the areas of atrophy associated with both FTD and SemD may underlie some the behavioral symptoms seen in the two disorders.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Brun A, Englund B, Gustafson L, et al. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry . 1994; 57: 416–418.
2.
Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology . 1998; 51: 1546–1554.
3.
Neary D, Snowden JS, Mann DM. The clinical pathological correlates of lobar atrophy. Dementia . 1993; 4: 154–159.
4.
Edwards-Lee T, Miller BL, Benson DF, et al. The temporal variant of frontotemporal dementia. Brain . 1997; 120: 1027–1040.
5.
Boone KB, Miller BL, Lee A, Berman N, Sherman D, Stuss DT. Neuropsychological patterns in right versus left frontotemporal dementia. J Int Neuropsychol Soc . 1999; 5: 616–622.
6.
Snowden JS, Goulding PJ, Neary D. Semantic dementia: a form of circumscribed cerebral atrophy. Behavioural Neurology . 1989; 2: 167–182.
7.
Hodges JR, Patterson K, Oxbury S, Funnell E. Semantic dementia. Progressive fluent aphasia with temporal lobe atrophy. Brain . 1992; 115: 1783–1806.
8.
Mummery C, Patterson K, Price C, Ashburner J, Frackowiak R, Hodges J. A voxel-based morphometry study of semantic dementia: relationship between temporal lobe atrophy and semantic memory. Ann Neurol . 2000; 47: 36–45.
9.
Galton CJ, Patterson K, Graham K, et al. Differing patterns of temporal atrophy in Alzheimer’s disease and semantic dementia. Neurology . 2001; 56: 216–225.
10.
Chan D, Fox NC, Scahill RI, et al. Patterns of temporal lobe atrophy in semantic dementia and Alzheimer’s disease. Ann Neurol . 2001; 49: 433–442.
11.
Perry RJ, Hodges JR. Differentiating frontal and temporal variant frontotemporal dementia from Alzheimer’s disease. Neurology 2000;54:2277–2284.
12.
Bozeat S, Gregory CA, Ralph MA, Hodges JR. Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer’s disease? J Neurol Neurosurg Psychiatry 2000;69:178–186.
13.
Vandenberghe R, Price C, Wise R, Josephs O, Frackowiak RSJ. Functional anatomy of a common semantic system for words and pictures. Nature . 1996; 383: 254–256.
14.
Gorno–Tempini ML, Price CJ, Josephs O, et al. The neural systems sustaining face and proper-name processing. Brain . 1998; 121: 2103–2118.
15.
Fukui T, Kertesz A. Volumetric study of lobar atrophy in Pick complex and Alzheimer’s disease. Journal of Neurol Sci . 2000; 174: 111–121.
16.
Ashburner J, Friston KJ. Voxel-based morphometry–the methods. Neuroimage . 2000; 11: 805–821.
17.
Eslinger PJ. Orbital frontal cortex: historical and contemporary views about its behavioral and physiological significance. An introduction to special topic papers: part I. Neurocase . 1999; 5: 225–229.
18.
Galton CJ, Patterson K, Xuereb JH, Hodges JR. Atypical and typical presentations of Alzheimer’s disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 2000;123 Pt 3:484–498.
19.
Read SL, Miller BL, Mena I, Kim R, Itabashi H, Darby A. SPECT in dementia: clinical and pathological correlation. J Am Geriatr Soc . 1995; 43: 1243–1247.
20.
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the mental state of patients for the clinician. J Psychiat Res . 1975; 12: 189–198.
21.
Delis DC, Lucas JA, Kopelman MD. Memory. In: Fogel BS, Schiffer RB, Rao SM, eds. Synopsis of neuropsychiatry. Philadelphia: Lippincott, Williams & Wilkins; 2000:169–191.
22.
Kaplan E, Goodglass H, Wintraub S. The Boston Naming Test. Philadelphia: Lea and Febiger, 1983.
23.
Reitan RM. Validity of the Trailmaking Test as an indication of organic brain damage. Percept Mot Skills . 1958; 8: 271–276.
24.
Cummings JL. The Neuropsychiatric Inventory. Assessing psychopathology in dementia patients. Neurology . 1997; 48: S10–16.
25.
Levy ML, Miller BL, Cummings JL, Fairbanks LA, Craig A. Alzheimer disease and frontotemporal dementias. Behavioral distinctions. Arch Neurol . 1996; 53: 687–690.
26.
Evans AC, Kamber M, Collins DL, Macdonald D. An MRI-based probabilistic atlas of neuroanatomy. In: Shorvon S, Fish D, Andermann F, Bydder GM, Stefan H, eds. Magnetic resonance scanning and epilepsy: Plenum Press; 1994:263–274.
27.
Ashburner J, Friston K. Multimodal image coregistration and partitioning–a unified framework. Neuroimage . 1997; 6: 209–217.
28.
Friston K, Holmes A, Worsley K, Poline J-P, Frith C, Frackowiak R. Statistical parametric map in functional imaging: a general linear approach. Hum Brain Mapp . 1995; 2: 189–210.
29.
Duvornoy HM. The human brain. Surface, three-dimensional sectional anatomy with MRI, and blood supply. New York: Springer-Verlag Wein; 1999.
30.
Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain: 3-Dimensional proportional system; an approach to cerebral imaging. Stuttgart: George Thieme Verlag; 1988.
31.
Rylander G. Personality changes after operations on the frontal lobes. Acta Psychiatr Scand (suppl) 1939; 20.
32.
Eslinger PJ, Damasio AR. Severe disturbance of higher cognition after bilateral frontal lobe ablation: patient EVR. Neurology . 1985; 35: 1731–1741.
33.
Damasio H, Grabowski T, Frank R, Galaburda AM, Damasio AR. The return of Phineas Gage: clues about the brain from the skull of a famous patient. Science . 1994; 264: 1102–1105.
34.
Rolls ET, Hornak J, Wade D, McGrath J. Emotion-related learning in patients with social and emotional changes associated with frontal lobe damage. J Neurol Neurosurg Psychiatry . 1994; 57: 1518–1524.
35.
Bechara A, Tranel D, Damasio H, Damasio AR. Failure to respond autonomically to anticipated future outcomes following damage to prefrontal cortex. Cereb Cortex . 1996; 6: 215–225.
36.
Rolls ET. The orbitofrontal cortex and reward. Cereb Cortex . 2000; 10: 284–294.
37.
Saver JL, Damasio AR. Preserved access and processing of social knowledge in a patient with acquired sociopathy due to ventromedial frontal damage. Neuropsychologia . 1991; 29: 1241–1249.
38.
Miller BL, Darby A, Benson DF, Cummings JL, Miller MH. Aggressive, socially disruptive and antisocial behaviour associated with fronto-temporal dementia. Br J Psychiatry . 1997; 170: 150–154.
39.
Chui H, Willis L. Vascular diseases of the frontal lobes. In: Miller BL, Cummings JL, eds. The human frontal lobes. New York: Guilford; 1999: 370–401.
40.
Shima K, Tanji J. Role for cingulate motor area cells in voluntary movement selection based on reward. Science . 1998; 282: 1335–1338.
41.
Graybiel AM, Rauch SL. Toward a neurobiology of obsessive-compulsive disorder. Neuron . 2002; 28: 343–347.
42.
Mendez MF, Perryman KM, Miller BL, Swartz JR, Cummings JL. Compulsive behaviors as presenting symptoms of frontotemporal dementia. J Geriatr Psychiatry Neurol . 1997; 10: 154–157.
43.
Augustine JR. Circuitry and functional aspects of the insular lobe in primates including humans. Brain Res Brain Res Rev 1996;22:229–244.
44.
Critchley HD, Elliott R, Mathias CJ, Dolan RJ. Neural activity relating to generation and representation of galvanic skin conductance responses: a functional magnetic resonance imaging study. J Neurosci . 2000; 20: 3033–3040.
45.
Damasio AR. The somatic marker hypothesis and the possible functions of the prefrontal cortex. Philosophical Transactions of the Royal Society of London, Series B. Biological Sciences . 1996; 351: 1413–1420.
46.
Dronkers NF. A new brain region for coordinating speech articulation. Nature . 1996; 384: 159–161.
47.
Lavenu I, Pasquier F, Lebert F, Petit H, Van der Linden M. Perception of emotion in frontotemporal dementia and Alzhei-mer disease. Alzheimer Dis Assoc Disord . 1999; 13: 96–101.
48.
Snowden JS, Bathgate D, Varma A, Blackshaw A, Gibbons ZC, Neary D. Distinct behavioural profiles in frontotemporal dementia and semantic dementia. J Neurol Neurosurg Psychiatry . 2001; 70: 323–332.
49.
Perry RJ, Rosen HR, Kramer JH, Beer JS, Levenson RL, Miller BL. Hemispheric dominance for emotions, empathy and social behaviour: evidence from right and left handers with frontotemporal dementia. Neurocase . 2001; 7: 145–160.
50.
Amaral DG, Price JL, Pitkanen A, Carmichael ST. Anatomical organization of the primate amygdaloid complex. In: Aggleton JP, ed. The amygdala: neurobiological aspects of emotion, memory and mental dysfunction. New York: Wiley-Liss; 1992: 1–66.
51.
Adolphs R, Tranel D, Hamann S, et al. Recognition of facial emotion in nine individuals with bilateral amygdala damage. Neuropsychologia . 1999; 37: 1111–1117.
52.
Hornak J, Rolls ET, Wade D. Face and voice expression identification in patients with emotional and behavioural changes following ventral frontal lobe damage. Neuropsychologia . 1996; 34: 247–261.
53.
Buchel C, Dolan RJ, Armony JL, Friston KJ. Amygdala-hippocampal involvement in human aversive trace conditioning revealed through event-related functional magnetic resonance imaging. J Neurosci . 1999; 19: 10869–10876.
54.
Buchel C, Dolan RJ. Classical fear conditioning in functional neuroimaging. Curr Opin Neurobiol . 2000; 10: 219–223.
55.
Phillips ML, Young AW, Scott SK, et al. Neural responses to facial and vocal expressions of fear and disgust. Proceedings of the Royal Society of London Series B. Biological Sciences . 1998; 265: 1809–1817.
56.
Gorno–Tempini ML, Pradelli S, Serafini M, et al. Explicit and incidental facial expression processing: an fMRI study. Neuroimage . 2001; 14: 465–473.
57.
Franzen EA, Myers RE. Neural control of social behavior: prefrontal and anterior temporal cortex. Neuropsychologia . 1972; 11: 141–157.

Information & Authors

Information

Published In

Neurology®
Volume 58Number 2January 22, 2002
Pages: 198-208
PubMed: 11805245

Publication History

Received: May 4, 2001
Accepted: September 27, 2001
Published online: January 22, 2002
Published in print: January 22, 2002

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

H. J. Rosen, MD
From the University of California at San Francisco Department of Neurology (Drs. Rosen, Gorno–Tempini, Goldman, Perry, Weiner, Kramer, and Miller), UCSF Memory and Aging Center (Drs. Rosen, Gorno–Tempini, Goldman, Perry, Kramer, and Miller), San Francisco Veterans Affairs Hospital Magnetic Resonance Spectroscopy Unit (Drs. Schuff and Weiner), University of California at San Francisco Department of Radiology (Drs. Schuff, Weiner, and Feiwell), CA.
M. L. Gorno–Tempini, MD
From the University of California at San Francisco Department of Neurology (Drs. Rosen, Gorno–Tempini, Goldman, Perry, Weiner, Kramer, and Miller), UCSF Memory and Aging Center (Drs. Rosen, Gorno–Tempini, Goldman, Perry, Kramer, and Miller), San Francisco Veterans Affairs Hospital Magnetic Resonance Spectroscopy Unit (Drs. Schuff and Weiner), University of California at San Francisco Department of Radiology (Drs. Schuff, Weiner, and Feiwell), CA.
W. P. Goldman, PhD
From the University of California at San Francisco Department of Neurology (Drs. Rosen, Gorno–Tempini, Goldman, Perry, Weiner, Kramer, and Miller), UCSF Memory and Aging Center (Drs. Rosen, Gorno–Tempini, Goldman, Perry, Kramer, and Miller), San Francisco Veterans Affairs Hospital Magnetic Resonance Spectroscopy Unit (Drs. Schuff and Weiner), University of California at San Francisco Department of Radiology (Drs. Schuff, Weiner, and Feiwell), CA.
R. J. Perry, MD
From the University of California at San Francisco Department of Neurology (Drs. Rosen, Gorno–Tempini, Goldman, Perry, Weiner, Kramer, and Miller), UCSF Memory and Aging Center (Drs. Rosen, Gorno–Tempini, Goldman, Perry, Kramer, and Miller), San Francisco Veterans Affairs Hospital Magnetic Resonance Spectroscopy Unit (Drs. Schuff and Weiner), University of California at San Francisco Department of Radiology (Drs. Schuff, Weiner, and Feiwell), CA.
N. Schuff, PhD
From the University of California at San Francisco Department of Neurology (Drs. Rosen, Gorno–Tempini, Goldman, Perry, Weiner, Kramer, and Miller), UCSF Memory and Aging Center (Drs. Rosen, Gorno–Tempini, Goldman, Perry, Kramer, and Miller), San Francisco Veterans Affairs Hospital Magnetic Resonance Spectroscopy Unit (Drs. Schuff and Weiner), University of California at San Francisco Department of Radiology (Drs. Schuff, Weiner, and Feiwell), CA.
M. Weiner, MD
From the University of California at San Francisco Department of Neurology (Drs. Rosen, Gorno–Tempini, Goldman, Perry, Weiner, Kramer, and Miller), UCSF Memory and Aging Center (Drs. Rosen, Gorno–Tempini, Goldman, Perry, Kramer, and Miller), San Francisco Veterans Affairs Hospital Magnetic Resonance Spectroscopy Unit (Drs. Schuff and Weiner), University of California at San Francisco Department of Radiology (Drs. Schuff, Weiner, and Feiwell), CA.
R. Feiwell, MD
From the University of California at San Francisco Department of Neurology (Drs. Rosen, Gorno–Tempini, Goldman, Perry, Weiner, Kramer, and Miller), UCSF Memory and Aging Center (Drs. Rosen, Gorno–Tempini, Goldman, Perry, Kramer, and Miller), San Francisco Veterans Affairs Hospital Magnetic Resonance Spectroscopy Unit (Drs. Schuff and Weiner), University of California at San Francisco Department of Radiology (Drs. Schuff, Weiner, and Feiwell), CA.
J. H. Kramer, PsyD
From the University of California at San Francisco Department of Neurology (Drs. Rosen, Gorno–Tempini, Goldman, Perry, Weiner, Kramer, and Miller), UCSF Memory and Aging Center (Drs. Rosen, Gorno–Tempini, Goldman, Perry, Kramer, and Miller), San Francisco Veterans Affairs Hospital Magnetic Resonance Spectroscopy Unit (Drs. Schuff and Weiner), University of California at San Francisco Department of Radiology (Drs. Schuff, Weiner, and Feiwell), CA.
B. L. Miller, MD
From the University of California at San Francisco Department of Neurology (Drs. Rosen, Gorno–Tempini, Goldman, Perry, Weiner, Kramer, and Miller), UCSF Memory and Aging Center (Drs. Rosen, Gorno–Tempini, Goldman, Perry, Kramer, and Miller), San Francisco Veterans Affairs Hospital Magnetic Resonance Spectroscopy Unit (Drs. Schuff and Weiner), University of California at San Francisco Department of Radiology (Drs. Schuff, Weiner, and Feiwell), CA.

Notes

Address correspondence and reprint requests to Dr. Howard Rosen, UCSF Department of Neurology, Memory and Aging Center, 350 Parnassus Ave., Suite 800, Box 1207, San Francisco, CA 94143-1207; e-mail: [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Variation in brain aging: A review and perspective on the utility of individualized approaches to the study of functional networks in aging, Neurobiology of Aging, 147, (68-87), (2025).https://doi.org/10.1016/j.neurobiolaging.2024.11.010
    Crossref
  2. Frontotemporal dementia, Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease, (35-57), (2025).https://doi.org/10.1016/B978-0-443-19176-3.00032-7
    Crossref
  3. Neuroimaging in dementia, Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease, (213-224), (2025).https://doi.org/10.1016/B978-0-443-19041-4.00070-4
    Crossref
  4. Personalized Dose Selection for Treatment of Patients with Neuropsychiatric Disorders Using tDCS, Brain Sciences, 14, 12, (1162), (2024).https://doi.org/10.3390/brainsci14121162
    Crossref
  5. Deep learning-based quantification of brain atrophy using 2D T1-weighted MRI for Alzheimer’s disease classification, Frontiers in Aging Neuroscience, 16, (2024).https://doi.org/10.3389/fnagi.2024.1423515
    Crossref
  6. An anti-sortilin affibody-peptide fusion inhibits sortilin-mediated progranulin degradation, Frontiers in Immunology, 15, (2024).https://doi.org/10.3389/fimmu.2024.1437886
    Crossref
  7. Plasma Neurofilament Light Relates to Divergent Default and Salience Network Connectivity in Alzheimer’s Disease and Behavioral Variant Frontotemporal Dementia, Journal of Alzheimer’s Disease, 99, 3, (965-980), (2024).https://doi.org/10.3233/JAD-231251
    Crossref
  8. Unravelling the genetic overlap between sporadic ALS and C9orf72-related ALS: a comprehensive comparative investigation, Minerva Biotechnology and Biomolecular Research, 36, 2, (2024).https://doi.org/10.23736/S2724-542X.24.03066-9
    Crossref
  9. Air pollution: a latent key driving force of dementia, BMC Public Health, 24, 1, (2024).https://doi.org/10.1186/s12889-024-19918-4
    Crossref
  10. Chapter 10. Alzheimer’s Disease and Other Dementing Illnesses, Clinical Manual of Neuropsychiatry, (311-338), (2024).https://doi.org/10.1176/appi.books.9781615378302.lg10
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Figures

Tables

Media

Share

Share

Share article link

Share